High cholesterol trials recruiting in North Carolina

All High cholesterol trials nationally

Cities in North Carolina

Recruiting trials in North Carolina

• A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin and Placebo on LDL-C in LLT-naïve Patients.
  NCT07619131 · Phase: Phase 3 · Ages: 18 Years to 130 Years · Sex: All (male and female) · North Carolina: Durham, Morehead City, Statesville, Wilmington
• A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias
  NCT07491172 · Phase: Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female) · North Carolina: Durham, High Point
• A Study of VERVE-102 in Patients With Familial Hypercholesterolemia or Premature Coronary Artery Disease
  NCT06164730 · Phase: Phase 1 · Ages: 18 Years to 70 Years · Sex: All (male and female) · North Carolina: High Point
• A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and Concomitant Hypercholesterolemia
  NCT07610278 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · North Carolina: Monroe
• A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia
  NCT07477704 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · North Carolina: Durham, Wilmington
• Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders Trial
  NCT06488105 · Phase: Phase 2 · Ages: 40 Years to 75 Years · Sex: All (male and female) · North Carolina: Winston-Salem
• Healthy Living Anson Study
  NCT07126587 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 99 Years · Sex: All (male and female) · North Carolina: Chapel Hill
• Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
  NCT06909565 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · North Carolina: Asheville, Charlotte, Fayetteville, Greensboro
• Pharmacogenomic Informed Statin Prescribing
  NCT06568601 · Phase: Not applicable (e.g. observational or device study) · Ages: 40 Years to 75 Years · Sex: All (male and female) · North Carolina: Durham
• Study of MAR001 in Adults With Elevated Triglycerides and Remnant Cholesterol
  NCT07028749 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · North Carolina: Greensboro, Winston-Salem